FdaApplication
BLA 761150
Identifiers
- fda_app_no: BLA761150
Properties
| Property | Value |
|---|---|
| applicant_name | TERSERA THERAPEUTICS LLC |
| application_type | BLA |
| approval_date | 2020-12-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MARGENZA | MARGETUXIMAB-CMKB | 250MG/10ML (25MG/ML) | Injection |
1 product